|4Oct 28, 7:00 AM ET

OMEROS CORP 4

4 · OMEROS CORP · Filed Oct 28, 2013

Insider Transaction Report

Form 4
Period: 2013-10-24
Aspiri Ray
Director
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-10-245,0000 total
    Exercise: $5.92From: 2011-05-26Exp: 2020-05-27Common Stock (5,000 underlying)
  • Exercise/Conversion

    Common Stock

    2013-10-24$5.92/sh+5,000$29,60030,306 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-10-245,0000 total
    Exercise: $4.53From: 2012-05-31Exp: 2021-05-26Common Stock (5,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-10-245,0000 total
    Exercise: $10.19From: 2013-05-23Exp: 2022-05-31Common Stock (5,000 underlying)
  • Exercise/Conversion

    Common Stock

    2013-10-24$4.53/sh+5,000$22,65035,306 total
  • Exercise/Conversion

    Common Stock

    2013-10-24$10.19/sh+5,000$50,95040,306 total
  • Exercise/Conversion

    Common Stock

    2013-10-24$7.56/sh+10,000$75,60025,306 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-10-2410,0000 total
    Exercise: $7.56Exp: 2019-12-14Common Stock (10,000 underlying)
Holdings
  • Common Stock

    (indirect: By LLC)
    186,872
Footnotes (2)
  • [F1]The reporting person is the managing partner and a member of Aspiri Enterprises LLC, the owner of the securities.
  • [F2]This option vested and became exercisable in equal annual installments over a three-year period beginning on the date of the grant (Dec. 15, 2009).

Documents

2 files